News | News By Subject | News by Disease News By Date | Search News

 News

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
After Merck & Co. (MRK) & Eli Lilly (LLY) Alzheimer’s Failures, A Look at 7 Companies Still on the Hunt     2/17/2017
3 Biotechs With the Biggest and Most Promising Pipelines     2/16/2017
ArmaGen CEO: Phase II Data Shows Cognitive Improvement in Juvenile Hurler Syndrome Patients     2/16/2017
Another Drug Bites the Dust: Merck & Co. (MRK) Stops Late-Stage Alzheimer’s Study     2/16/2017
New FDA Report Cites 22 Drugs That Passed Phase II But Crashed and Burned in Phase III     2/8/2017
GlaxoSmithKline (GSK)'s Incoming CEO Preps for Deals, R&D Decisions on New Drugs     2/7/2017
These 5 Biotechs Are Battling Over the $10 Billion Hemophilia Market     2/6/2017
3rd Stemline (STML) Patient Died in Clinical Trial One Day Before $45 Million Public Offering     2/3/2017
Why This Big Biotech Could be Biogen (BIIB)'s Downfall     2/3/2017
Pfizer (PFE) Quietly Kills 3 Pipeline Programs     2/2/2017
6 Biopharma Companies Face Catalysts in February     1/31/2017
JPM17: Why the Key to Gene Therapy Could be in an Old Bay Area Warehouse     1/16/2017
JPM17: How Celgene (CELG) Wowed Yet Again     1/11/2017
Finding a Complementary Secondary Endpoint in Lupus Clinical Trials     1/10/2017
4 Fatal Deaths in Seattle Genetics (SGEN)' Early-Stage Trials of AML Drug     12/30/2016

Featured Stories
Allergan (AGN) R&D Chief Reveals 6 Drugs That Could be Potential Blockbusters     2/14/2017
5 Daring Biopharmas Mixing Drugs With Marijuana     2/6/2017
Scientists Highlight the Hopes and Fears of Cellectis (ALCLS)' CAR-T     1/26/2017
Novartis AG (NVS) Shows Off 13 Potential Blockbusters in Pipeline     1/25/2017
3 Drugs Heading To The FDA Soon     12/12/2016
10 Drugs That Could be Johnson & Johnson (JNJ)'s New Blockbusters     11/2/2016
A Look at BioMarin (BMRN)'s Potential Blockbuster and the Science Behind It All     10/21/2016
4 Small Biotechs That Could Give Gilead (GILD), Merck & Co. (MRK) Pfizer (PFE) Some Competition With NASH     10/7/2016
Why SCYNEXIS, Inc. (SCYX) Is Making A Run     10/7/2016
Despite Trial Deaths, Juno (JUNO) Could Still Be the CAR-T Leader     9/13/2016
In Juno (JUNO) Patient Deaths, Echoes Seen Of Earlier Failed Company Dendreon (DNDN)     7/11/2016
ASCO2016: What's Next For Cancer-Killing T-Cells After Strong ASCO Showings     6/8/2016
Down's Syndrome 'Can Be Treated With Green Tea,' Centre for Genomic Regulation Study     6/7/2016
Pharma's Big New Cancer Drug May Be An Old Red Dye     2/26/2016
Why Investors Shouldn't Freak Out Over Vertex (VRTX)'s Latest Trial Results     3/24/2015
Capricor Therapeutics, Inc. Terminates Natriuretic Peptide Program Deal With The Mayo Clinic     2/17/2017
ArmaGen Reports Preliminary Evidence Of Cognitive Improvement In Children With Hurler Syndrome (MPS I) Treated With AGT-181     2/17/2017
Ascendis Announces Publication Of Comprehensive Results From Randomized, Active-Controlled Phase 2 Trial Of Once-Weekly Transcon Growth Hormone In Pediatric Patients     2/17/2017
Viriom Reports Positive Findings In Phase IIb Study Of Elpida As Compared To Efavirenz In Combination With TDF/FTC At CROI 2017     2/17/2017
Kalytera Therapeutics To Announce Phase IIa Clinical Study Results Investigating CBD For The Treatment Of Acute Graft Versus Host Disease     2/17/2017
Adamas Pharma (ADMS) To Present New ADS-5102 Data From Phase II Trial In Walking Impairment Associated With Multiple Sclerosis At ACTRIMS Forum 2017     2/17/2017
Heat Biologics Presents Immune Data On Its HS-410 Phase II Bladder Cancer Trial At The Genitourinary Cancers Symposium     2/17/2017
Noble Capital Markets Initiates Research Coverage On ESSA Pharma     2/17/2017
Data Presented At CROI Show CytoDyn (CYDY)’s Pro 140 As A Single Agent Provided Maximal Virologic Suppression In HIV Patients For Nearly Two Years     2/16/2017
AEterna Zentaris (AEZS) Announces Zoptrex Presentation In Prostate Cancer At 2017 Genitourinary Cancers Symposium     2/15/2017
TapImmune (TPIV) Advances TPIV 200 Phase II Triple-Negative Breast Cancer Trial After Favorable DSMB Safety Review     2/15/2017
Berg Initiates Phase I/II Monotherapy Trial Of BPM 31510-IV In Patients With Glioblastoma Multiforme (GBM)     2/15/2017
Aviragen (AVIR) Tanks Some More After Reporting a Second Trial Failure This Month     2/14/2017
Hutchison China MediTech (Chi-Med): Savolitinib PRCC Results Presentation At ASCO GU     2/14/2017
Hutchison China MediTech (Chi-Med) And AstraZeneca PLC (AZN) Present Savolitinib Papillary Renal Cell Carcinoma Phase II Results at 2017 Genitourinary Cancers Symposium     2/14/2017

More News
No News Posted on that date

Career Tips
5 Best U.S. Regions for Life Science Jobs     2/16/2017
Here Are 5 Tricky Job Interview Questions You Might Get at Genentech (RHHBY), Regeneron (REGN), and Stratos     2/16/2017
How to Write the Best Cover Letter for a Research Scientist Job     2/16/2017
Real Life Employees Talk About Working At Allergan (AGN), Seattle Genetics (SGEN) And Shire (SHPG)     2/16/2017
How New Scientists Can Navigate The Tricky Waters Of A Life Science Career     2/16/2017
Biotech CEO To Job Seekers: How To Switch Out Before Burning Out On The Job     2/16/2017
Tired Of The U.S.? 6 Tips To Landing A Life Science Job Overseas     2/16/2017
Must-Read Tips For Getting Hired When You Don't Qualify For That Life Science Job     2/16/2017
Attention Bay Area: Chan-Zuckerberg's BIOHUB is Hiring Lots of Scientists     2/8/2017
Warning: Here's The Heartbreaking Truth About Postdoc Job Salaries in Life Sciences     2/8/2017
Explosion of Big Data Jobs: These Biotechs Are Hiring Huge Numbers of Data Scientists     2/3/2017
10 Unmistakable Signs It's Time To Kiss Your Biotech Employer Goodbye     2/1/2017
Don't Waste Your Time: Use These Strategies to Land That Life Science Job     2/1/2017
Lab Work Not for You: 10 Reasons Life Sci Grads Should Consider Recruiting     2/1/2017
Validation Engineer: How To Get This In-Demand Biotech Job     2/1/2017

Other News Sources
//-->